Your browser doesn't support javascript.
Medication and substance use increases among people using cannabis medically during the COVID-19 pandemic.
Boehnke, Kevin F; McAfee, Jenna; Ackerman, Joshua M; Kruger, Daniel J.
  • Boehnke KF; Anesthesiology Department and Chronic Pain and Fatigue Research Center, University of Michigan Medical School, Ann Arbor, MI, United States. Electronic address: kboehnke@med.umich.edu.
  • McAfee J; Anesthesiology Department and Chronic Pain and Fatigue Research Center, University of Michigan Medical School, Ann Arbor, MI, United States.
  • Ackerman JM; Psychology Department, University of Michigan, Ann Arbor, MI, United States.
  • Kruger DJ; Population Studies Center, University of Michigan, Ann Arbor, MI, United States.
Int J Drug Policy ; 92: 103053, 2021 06.
Article in English | MEDLINE | ID: covidwho-965665
ABSTRACT

BACKGROUND:

The ongoing COVID-19 pandemic strains the medical system, limiting access to healthcare services. Many people use cannabis medically for chronic health conditions and as a substitute for other medications. As such, changes in cannabis access associated with COVID-19 may result in increased non-cannabis drug use.

METHODS:

We recruited N = 353 individuals through Amazon Mechanical Turk who reported current medical cannabis use in April and May of 2020. We assessed the effects of the COVID-19 pandemic on patterns of medication and substance use, as well as on cannabis use patterns.

RESULTS:

Over half of participants either started using or increased use of medications or substances because of the COVID-19 pandemic, most commonly alcohol and sleep aids. Over a third of participants increased cannabis use while 25% decreased cannabis use. Approximately 40% of participants who increased or started use of medications/substances (other than cannabis) reported doing so because of changed access to medical cannabis.

CONCLUSION:

The reported increase in drug use among people using medical cannabis is concerning. Because the pandemic will likely continue for months (or even years), having a better understanding of why this is occurring is critical for developing effective harm-reduction strategies in this population.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Cannabis / Substance-Related Disorders / COVID-19 Type of study: Observational study Topics: Long Covid Limits: Humans Language: English Journal: Int J Drug Policy Journal subject: Public Health / Substance-Related Disorders Year: 2021 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Cannabis / Substance-Related Disorders / COVID-19 Type of study: Observational study Topics: Long Covid Limits: Humans Language: English Journal: Int J Drug Policy Journal subject: Public Health / Substance-Related Disorders Year: 2021 Document Type: Article